Pleiotropic effects of LDL apheresis

Atherosclerosis Supplements

Volumn 10, Issue 5, 2009, Pages 53-55

  Ramunni, Alfonso ^a   Burzo, Maria ^a   Vernò, Lucia ^a   Brescia, Paola ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Endothelial progenitor cells; LDL apheresis; Pleiotropic effects

Indexed keywords

BIOLOGICAL MARKER; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

APHERESIS; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; ENDOTHELIUM CELL; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC OPTIC NEUROPATHY; LONG TERM CARE; MICROCIRCULATION; NON ARTERITIC ISCHEMIC OPTIC NEUROPATHY; PLEIOTROPY; PRIORITY JOURNAL; STEM CELL; SUDDEN DEAFNESS; TREATMENT RESPONSE; UREMIA; VASODILATATION;

BIOLOGICAL MARKERS; BLOOD COMPONENT REMOVAL; BLOOD VISCOSITY; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HEMODYNAMICS; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS, LDL; MICROCIRCULATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 72649086107     PISSN: 15675688     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5688(09)71811-2     Document Type: Article

References (29)

1. Stoffel W., Borberg H., and Greve V. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolemia. Lancet 2 (1981) 1005-1007
2. Aengevaeren W.R.M., Kroon A.A., Stalenhoef A., Uijen G.J., and van der Werf T. Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. LDL-Apheresis Atherosclerosis Regression Study (LAARS). J Am Coll Cardiol 28 (1996) 1696-1704
3. Matsuzaki M., Hiramori K., Imaizumi T., et al. Intravascular ultrasound evaluation of coronary plaque regression by low-density lipoprotein apheresi in familial hypercholesterolemia. The Low-Density Lipoprotein Apheresis Coronary Morphology and Reserve Trial (LACMART). J Am Coll Cardiol 40 (2002) 220-227
4. Nishimura S., Sekiguchi M., Kano T., et al. Effects of intensive lipid lowering by low-density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan Low-density Lipoprotein Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS). Atherosclerosis 144 (1999) 409-417
5. Kroon A.A., Aengevaeren W.R., van den Werf T., et al. LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation 93 (1996) 1826-1835
6. Richter W.O., Donner M.G., Hofling B., et al. Long-term effect of low- density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia. Metabolism 47 (1998) 863-868
7. Mabuchi H., Koizumi J., Shimizu M., et al. Long-term efficacy of low- density lipoprotein aapheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group. Am J Cardiol 82 (1998) 1489-1495
8. Wang Y., Blessing F., Walli A.K., et al. Effects of heparin-mediated extracorporeal low-density lipoprotein precipitation beyond lowering proatherogenic lipoproteins-reduction of circulating proinflammatory and procoagulatory markers. Atherosclerosis 175 (2004) 145-150
9. Jaeger B.R., Goehring P., Schirmer J., et al. Consistent lowering of clotting factors for the treatment of acute cardiovascular syndromes and hypercoagulability: a different pathophysiological approach. Ther Apher 5 (2001) 252-259
10. Schuff-Werner, Schultz E., Seyde W.C., et al. Improved hemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP). Eur J Clin Invest 19 (1989) 30-37
11. Moriarty P.M., Cheryl A.G., Kensey K.R., et al. Effect of low-density lipoprotein cholesterol apheresis on blood viscosity. Am J Cardiol 93 (2004) 1044-1046
12. Tamai O., Matsuoka H., Itabe H., et al. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 95 (1997) 76-82
13. Ebihara I., Sato T., Hirayama K., et al. Blood flow analysis of the head and lower limbs by the laser doppler blood flowmeter during LDL apheresis. Ther Apher Dial 11 (2007) 325-330
14. Morimoto S., Yano Y., Maki K., and Sawada K. Efficacy of low-density lipoprotein apheresis in patients with peripheral arterial occlusive disease undergoing hemodialysis treatment. Am J Nephrol 27 (2007) 643-648
15. Ramunni A., Giancipoli G., Guerriero S., et al. LDL-apheresis accelerates the recovery of nonarteritic acute anterior ischemic optic neuropathy. Ther Apher 9 (2005) 53-58
16. Ramunni A., Giancipoli G., Saracino A., et al. LDL-apheresis in acute anterior ischemic optic neuropathy. Int J Artif Org 27 (2004) 337-341
17. Sukfull M., and for the Hearing Loss Study. Fibrinogen and LDL apheresis in treatment of sudden hearing loss. Lancet 360 (2002) 1811-1817
18. Ramunni A., Quaranta N., Saliani M.T., et al. Does a reduction of adhesion molecules by LDL apheresis have a role in the treatment of sudden hearing loss?. Ther Aphe Dial 10 (2006) 282-286
19. Quaranta N., Ramunni A., Brescia P., et al. Soluble intercellular adhesion molecule 1 and soluble vascular cell adhesion molecule 1 in sudden hearing loss. Otology & Neurology 29 (2008) 470-474
20. Guerriero S., Giancipoli G., Cantatore A., et al. LDL apheresis in the treatment of non-arteritic ischaemic optic neuropathy: a 6-month follow-up study. Eye 23 (2009) 1343-1344
21. Pusl T., Broedl U.C., Parhofer K.G., et al. Long-term LDL apheresis does not stably improve hemorheology in hypercholesterolemic patients with coronary artery disease. Clin Hemorheol Microcirc 41 (2009) 137-142
22. Ramunni A., Morrone L.F., Baldassarre g., et al. Effectiveness of long- term heparin-induced extracorporeal LDL precipitation (HELP) in improving coronary calcifications. Int J Artif Org 26 (2003) 252-255
23. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 138 (1999) S419-S420
24. Schwartz S.M., and Benditt E.P. Clustering of replicating cells in aortic endothelium. Proc Natl Acad Sci U S A 73 2 (1976) 651-653
25. Gehling U.M., Ergün S., Schumacher U., Wagener C., et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95 10 (2000 May 15) 3106-3112
26. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
27. Dimmeler S., Aicher A., Vasa M., et al. HMG-CoA reductase (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108 (2001) 391-397
28. Bahlmann F.H., DeGroot K., Duckert T., et al. Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin. Kidney Int 64 (2003) 1648-1652
29. Strehlow K., Werner R., Berweiler J., et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 107 (2003) 3059-3065